Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study status is Withdrawn/Closed by sponsor with enrollment at 0, indicating no active recruitment.
    Difference
    0.5%
    Check dated 2025-11-03T12:11:38.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    36 days ago
    Change Detected
    Summary
    - Updated page to v3.2.0 and removed the Medullary thyroid carcinoma resource. - Added a government funding/operating-status notice directing users to NIH and OPM sites for current operations.
    Difference
    5%
    Check dated 2025-10-05T16:44:31.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Core content terminology updated from “Medullary thyroid gland carcinoma” to “Medullary thyroid carcinoma” and the release version updated to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T09:55:45.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed; no core content or pricing/availability changes detected.
    Difference
    0.2%
    Check dated 2025-09-14T00:16:03.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T21:17:09.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, as well as specific medical terms related to medullary thyroid gland carcinoma and associated treatments. Additionally, the version has been revised from v2.16.12 to v3.0.0.
    Difference
    5%
    Check dated 2025-08-30T15:42:16.000Z thumbnail image

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.